ERBB2 and adenocarcinoma: All the stages were represented at diagnosis: four patients with stage I, three patients with stage II, seven patients with stage III, and seven patients with stage IV disease.HER2 mutations occurred at a significantly higher frequency in female, never-smokers with adenocarcinoma when compared with HER2 negative patients.